Results
Alkem Q4 Revenue Up 14.6%, EBITDA Hits Record
Alkem Laboratories reported Q4 FY26 revenue growth of 14.6% to ₹36,033 million and record EBITDA of ₹5,174 million with 32.2% YoY growth.
International sales grew 25.4% YoY in Q4, with US sales up 26.
